Hi Kip, Thanks for the update. This should have really been included in the Shareholder Report. Not only for existing shareholders but for those new to Suda. By choosing not to make some mention does give cause for concern.
It would have also been nice to see a mention of how things were progressing with "Anagrelide" and if they are on track to complete DD in the six months indicated. This could actually be a huge windfall for Suda if the delivery method is proven successful.
GO THE EAGLES!!!
prescription medicine registration process, page-14
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $194.5M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 17.5¢ | $593.7K | 3.237M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 808467 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 507481 | 9 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| ALA (ASX) Chart |